| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $400.0M | $350.6M | $313.4M |
| YoY Revenue Growth % | +14.1% | +11.9% | — |
| Gross Profit | $289.7M | $246.9M | — |
| Gross Margin % | 72.4% | 70.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $13.3M | -$5.1M | -$18.1M |
| Operating Margin % | 3.3% | -1.5% | -5.8% |
| Net Income (GAAP) | -$638.0K | -$12.1M | -$15.6M |
| EBITDA (Normalized) | $21.6M | $3.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $40.3M | $46.8M | $34.6M |
| Capital Expenditures (CapEx) | $10.4M | $10.6M | — |
| Free Cash Flow (FCF) | $29.9M | $36.2M | $34.6M |
| FCF Margin % | 7.5% | 10.3% | 11.0% |
| Return on Invested Capital (ROIC %) | 11.7% | -4.7% | — |
| Cash & Short-Term Equivalents | $116.9M | $112.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $206.5M | $198.2M | — |